Measured in a cell proliferation assay using MCF‑7 human breast cancer cells in the presence of 2 μg/mL of heparin sodium. The ED50 for this effect is typically <21ng/mL.
Measured in a cell proliferation assay using MCF‑7 human breast cancer cells in the presence of 2 μg/mL of heparin sodium. The ED50 for this effect is typically <21ng/mL.
19.8 kDa, under reducing conditions; 19.8 kDa, under non-reducing conditions.
分子类型
蛋白质
产品线
biological_products
储存与运输
物理形态
冻干(Lyophilized)
储存缓冲液
Lyophilized from a sterile solution containing 20 mM phosphate buffer, pH7.4.
复溶
Centrifuge first and redissolve with deionized water to proposal concentration.
储存条件
-20°C储存
运输条件
超低温运输
稳定性与储存
在 4°C 下运输。储存温度为 -20°C 或 -80°C。避免冷冻/解冻循环。
图片
Recombinant Human FGF10 Protein (rp145913)-Protein Bioactivity Measured in a cell proliferation assay using MCF‑7 human breast cancer cells in the presence of 2 μg/mL of heparin sodium. The ED₅₀ for this effect is typically <21ng/mL.
Recombinant Human FGF10 Protein (rp145913)-SDS-PAGE 3μg/lane of Recombinant Human FGF10 Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing a single band at 19.8 kDa.
Recombinant Human FGF10 Protein (rp145913) - Protein Bioactivity Measured in a cell proliferation assay using MCF‑7 human breast cancer cells in the presence of 2 μg/mL of heparin sodium (H104201). The ED₅₀ for this effect is 1.7 ng/mL.